What is the generic name?

RISANKIZUMAB-RZAA

What is the Trade Name for RISANKIZUMAB-RZAA?

Skyrizi

What are the Indications for RISANKIZUMAB-RZAA?

• 1 INDICATIONS AND USAGE SKYRIZI is an interleukin-23 antagonist indicated for the treatment of: moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. ( 1.1 ) active psoriatic arthritis in adults. ( 1.2 ) 1.1 Plaque Psoriasis SKYRIZI ¬Æ is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. 1.2 Psoriatic Arthritis SKYRIZI is indicated for the treatment of active psoriatic arthritis in adults.

References: https://open.fda.gov/